Penumbra, Inc. (PEN)
NYSE: PEN · Real-Time Price · USD
358.53
+0.85 (0.24%)
Jan 22, 2026, 4:00 PM EST - Market closed
Penumbra Revenue
Penumbra had revenue of $354.69M in the quarter ending September 30, 2025, with 17.82% growth. This brings the company's revenue in the last twelve months to $1.33B, up 14.61% year-over-year. In the year 2024, Penumbra had annual revenue of $1.19B with 12.86% growth.
Revenue (ttm)
$1.33B
Revenue Growth
+14.61%
P/S Ratio
10.41
Revenue / Employee
$296,400
Employees
4,500
Market Cap
14.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.19B | 136.09M | 12.86% |
| Dec 31, 2023 | 1.06B | 211.39M | 24.95% |
| Dec 31, 2022 | 847.13M | 99.54M | 13.32% |
| Dec 31, 2021 | 747.59M | 187.18M | 33.40% |
| Dec 31, 2020 | 560.41M | 13.01M | 2.38% |
| Dec 31, 2019 | 547.41M | 102.47M | 23.03% |
| Dec 31, 2018 | 444.94M | 111.17M | 33.31% |
| Dec 31, 2017 | 333.76M | 70.45M | 26.75% |
| Dec 31, 2016 | 263.32M | 77.22M | 41.50% |
| Dec 31, 2015 | 186.10M | 60.59M | 48.27% |
| Dec 31, 2014 | 125.51M | 36.66M | 41.26% |
| Dec 31, 2013 | 88.85M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Koninklijke Philips | 20.86B |
| Zimmer Biomet Holdings | 8.01B |
| Smith & Nephew | 5.94B |
| STERIS | 5.70B |
| Bruker | 3.44B |
| Globus Medical | 2.77B |
| Bio-Rad Laboratories | 2.56B |
| Bio-Rad Laboratories | 2.56B |
PEN News
- 7 days ago - Boston Scientific to buy Penumbra in $14.5B deal to expand cardiovascular reach - Invezz
- 7 days ago - Penumbra Stock Jumps. It's Being Bought by Boston Scientific for $14.5 Billion. - Barrons
- 8 days ago - Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ‘fast-growing' vascular segments - Market Watch
- 8 days ago - Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock - WSJ
- 8 days ago - Boston Scientific to buy Penumbra in deal valued at $14.5 billion - Reuters
- 8 days ago - Penumbra, Inc. Provides Preliminary Update on Fourth Quarter and Full Year 2025 Financial Results - PRNewsWire
- 8 days ago - Boston Scientific announces agreement to acquire Penumbra, Inc. - PRNewsWire
- 10 days ago - Penumbra, Inc. (PEN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha